Literature DB >> 16815238

Antimicrobial barrier of an in vitro oral epithelial model.

Janet R Kimball1, Wipawee Nittayananta, Mitchell Klausner, Whasun O Chung, Beverly A Dale.   

Abstract

OBJECTIVE: Oral epithelia function as a microbial barrier and are actively involved in recognizing and responding to bacteria. Our goal was to examine a tissue engineered model of buccal epithelium for its response to oral bacteria and proinflammatory cytokines and compare the tissue responses with those of a submerged monolayer cell culture.
DESIGN: The tissue model was characterized for keratin and beta-defensin expression. Altered expression of beta-defensins was evaluated by RT-PCR after exposure of the apical surface to oral bacteria and after exposure to TNF-alpha in the medium. These were compared to the response in traditional submerged oral epithelial cell culture.
RESULTS: The buccal model showed expression of differentiation specific keratin 13, hBD1 and hBD3 in the upper half of the tissue; hBD2 was not detected. hBD1 mRNA was constitutively expressed, while hBD2 mRNA increased 2-fold after exposure of the apical surface to three oral bacteria tested and hBD3 mRNA increased in response to the non-pathogenic bacteria tested. In contrast, hBD2 mRNA increased 3-600-fold in response to bacteria in submerged cell culture. HBD2 mRNA increased over 100-fold in response to TNF-alpha in the tissue model and 50-fold in submerged cell culture. Thus, the tissue model is capable of upregulating hBD2, however, the minimal response to bacteria suggests that the tissue has an effective antimicrobial barrier due to its morphology, differentiation, and defensin expression.
CONCLUSIONS: The oral mucosal model is differentiated, expresses hBD1 and hBD3, and has an intact surface with a functional antimicrobial barrier.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16815238      PMCID: PMC2376809          DOI: 10.1016/j.archoralbio.2006.05.007

Source DB:  PubMed          Journal:  Arch Oral Biol        ISSN: 0003-9969            Impact factor:   2.633


  35 in total

Review 1.  Epithelial structural proteins of the skin and oral cavity: function in health and disease.

Authors:  R B Presland; B A Dale
Journal:  Crit Rev Oral Biol Med       Date:  2000

2.  Expression of the peptide antibiotics human beta defensin-1 and human beta defensin-2 in normal human skin.

Authors:  R S Ali; A Falconer; M Ikram; C E Bissett; R Cerio; A G Quinn
Journal:  J Invest Dermatol       Date:  2001-07       Impact factor: 8.551

3.  Expression of human beta-defensin-3 in gingival epithelia.

Authors:  Qian Lu; Lakshman P Samaranayake; Richard P Darveau; Lijian Jin
Journal:  J Periodontal Res       Date:  2005-12       Impact factor: 4.419

4.  Human beta defensin-1 and -2 expression in human pilosebaceous units: upregulation in acne vulgaris lesions.

Authors:  C M Chronnell; L R Ghali; R S Ali; A G Quinn; D B Holland; J J Bull; W J Cunliffe; I A McKay; M P Philpott; S Müller-Röver
Journal:  J Invest Dermatol       Date:  2001-11       Impact factor: 8.551

Review 5.  Cysteine proteases of Porphyromonas gingivalis.

Authors:  M A Curtis; J Aduse-Opoku; M Rangarajan
Journal:  Crit Rev Oral Biol Med       Date:  2001

6.  Permeability barrier properties of oral keratinocyte cultures: a model of intact human oral mucosa.

Authors:  L Selvaratnam; A T Cruchley; H Navsaria; P W Wertz; E P Hagi-Pavli; I M Leigh; C A Squier; D M Williams
Journal:  Oral Dis       Date:  2001-07       Impact factor: 3.511

7.  Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic.

Authors:  J Harder; J Bartels; E Christophers; J M Schroder
Journal:  J Biol Chem       Date:  2000-11-20       Impact factor: 5.157

8.  Localized antimicrobial peptide expression in human gingiva.

Authors:  B A Dale; J R Kimball; S Krisanaprakornkit; F Roberts; M Robinovitch; R O'Neal; E V Valore; T Ganz; G M Anderson; A Weinberg
Journal:  J Periodontal Res       Date:  2001-10       Impact factor: 4.419

9.  Microbial composition of supra- and subgingival plaque in subjects with adult periodontitis.

Authors:  L A Ximénez-Fyvie; A D Haffajee; S S Socransky
Journal:  J Clin Periodontol       Date:  2000-10       Impact factor: 8.728

10.  Inducible expression of human beta-defensin 2 by Fusobacterium nucleatum in oral epithelial cells: multiple signaling pathways and role of commensal bacteria in innate immunity and the epithelial barrier.

Authors:  S Krisanaprakornkit; J R Kimball; A Weinberg; R P Darveau; B W Bainbridge; B A Dale
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

View more
  14 in total

1.  Oral human β-defensin 2 in HIV-infected subjects with long-term use of antiretroviral therapy.

Authors:  Wipawee Nittayananta; Marisa Kemapunmanus; Korntip Amornthatree; Sineepat Talungchit; Hutcha Sriplung
Journal:  J Oral Pathol Med       Date:  2012-06-09       Impact factor: 4.253

2.  Development of a highly reproducible three-dimensional organotypic model of the oral mucosa.

Authors:  Anna Dongari-Bagtzoglou; Helena Kashleva
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

Review 3.  Defensins as anti-inflammatory compounds and mucosal adjuvants.

Authors:  Karl G Kohlgraf; Lindsey C Pingel; Deborah E Dietrich; Kim A Brogden
Journal:  Future Microbiol       Date:  2010-01       Impact factor: 3.165

4.  Three-Dimensional In Vitro Oral Mucosa Models of Fungal and Bacterial Infections.

Authors:  Fahimeh Tabatabaei; Keyvan Moharamzadeh; Lobat Tayebi
Journal:  Tissue Eng Part B Rev       Date:  2020-04-07       Impact factor: 6.389

5.  Streptococcus mutans strains recovered from caries-active or caries-free individuals differ in sensitivity to host antimicrobial peptides.

Authors:  E Phattarataratip; B Olson; B Broffitt; F Qian; K A Brogden; D R Drake; S M Levy; J A Banas
Journal:  Mol Oral Microbiol       Date:  2011-01-31       Impact factor: 3.563

6.  HIV type 1 fails to trigger innate immune factor synthesis in differentiated oral epithelium.

Authors:  Wipawee Nittayananta; Florian Hladik; Mitchell Klausner; Socorro Harb; Beverly A Dale; Robert W Coombs
Journal:  AIDS Res Hum Retroviruses       Date:  2009-10       Impact factor: 2.205

7.  FAD-I, a Fusobacterium nucleatum Cell Wall-Associated Diacylated Lipoprotein That Mediates Human Beta Defensin 2 Induction through Toll-Like Receptor-1/2 (TLR-1/2) and TLR-2/6.

Authors:  Sanghamitra Bhattacharyya; Santosh K Ghosh; Bhumika Shokeen; Betty Eapan; Renate Lux; Janna Kiselar; Stanley Nithianantham; Andrew Young; Pushpa Pandiyan; Thomas S McCormick; Aaron Weinberg
Journal:  Infect Immun       Date:  2016-04-22       Impact factor: 3.441

8.  Clinical manifestations associated with high titer of anti-streptolysin O in Behcet's disease.

Authors:  Sang Ho Oh; Kyu-Yeop Lee; Ju Hee Lee; Dongsik Bang
Journal:  Clin Rheumatol       Date:  2008-02-02       Impact factor: 2.980

Review 9.  Regenerative and engineered options for urethroplasty.

Authors:  Filippo Pederzoli; Gregory Joice; Andrea Salonia; Trinity J Bivalacqua; Nikolai A Sopko
Journal:  Nat Rev Urol       Date:  2019-06-06       Impact factor: 14.432

10.  Effects of whole cigarette smoke on human beta defensins expression and secretion by oral mucosal epithelial cells.

Authors:  Wen-Mei Wang; Pei Ye; Ya-Jie Qian; Ya-Fan Gao; Jing-Jing Li; Fang-Fang Sun; Wei-Yun Zhang; Xiang Wang
Journal:  Tob Induc Dis       Date:  2015-01-24       Impact factor: 2.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.